<DOC>
	<DOCNO>NCT02887209</DOCNO>
	<brief_summary>Insomnia problem approximately 75 % people live HIV , much high 6 % 10 % people insomnia general population . It currently unknown rate insomnia high among people live HIV , , often exclude clinical trial examine usefulness cognitive behavioural therapy insomnia ( CBT-I ) , recommend first-line treatment insomnia . Insomnia also associate poor immune function low medication adherence . The purpose study examine whether CBT-I useful reduce insomnia among people live HIV , examine whether counsel safe provide population . Other purpose explore whether reduce insomnia lead improve immune functioning medication adherence , collect feedback people 's experience receive CBT-I , examine psychological behavioural factor associate insomnia severity among people live HIV .</brief_summary>
	<brief_title>A Pragmatic Pilot Study Cognitive Behavioural Therapy Insomnia Among People Living With HIV</brief_title>
	<detailed_description>The prevalence insomnia general population range 6 % 10 % ( American Psychiatric Association , 2013 ) , whereas estimate prevalence among people live HIV ( PWH ) 73 % ( Rubinstein &amp; Selwyn , 1998 ) . Cognitive , behavioural , physiological , psychosocial explanation elevate prevalence propose ( Taibi , 2013 ) , however , lack consensus literature . Sleep disturbance associate disrupt immune function cellular level ( Taylor , Lichstein , &amp; Durrence , 2003 ) , well increase risk contract infectious disease ( Patel et al. , 2012 ) ; therefore , insomnia may particularly problematic PWH . Cognitive behavioural therapy insomnia ( CBT-I ; Edinger &amp; Carney , 2008 ) first-line treatment insomnia ( Qaseem et al. , 2016 ; Schutte-Rodin et al. , 2008 ) , medium large effect size report ( Okajima et al. , 2011 ) . CBT-I effective treat insomnia among individual comorbid medical disorder chronic pain ( Jungquist et al. , 2012 ) , fibromyalgia ( Martínez et al. , 2014 ) , cancer ( Garland et al. , 2014 ) . Surprisingly , study date examine efficacy CBT-I among PWH . The current study evaluate safety , feasibility , acceptability , effect CBT-I among 20 PWH use pragmatic pilot study design . An exit interview conduct elicit participant feedback treatment method use . Additional cross-sectional analysis examine predictor insomnia symptom severity sleep-related outcome among large sample ( n = 60 ) . This first study examine impact CBT-I among PWH .</detailed_description>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<criteria>18 year age old able understand communicate English capable providing informed consent presence insomnia base screener questionnaire cutoff score ≥ 15 Insomnia Severity Index HIVseropositive willing provide HIV viral load CD4 count blood work within past two month active suicidal ideation psychotic symptom unmanaged bipolar disorder presence severe alcohol substance use disorder accord Diagnostic Statistical Manual Mental Disorders ( DSM ) 5 criterion hypnotic dependence presence breathingrelated sleep disorder ( obstructive sleep apnea hypopnea , central sleep apnea , sleeprelated hypoventilation ) , circadian rhythm sleepwake disorder work shift work frequent time zone travel course study contingent inconsistent hypnotic use , anticipated change hypnotic medication dose course study receive psychotherapy insomnia mental disorder course study presence AIDSdefining opportunistic infection and/or CD4 count &lt; 200</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>